ロード中...
Do LORIS trial eligibility criteria identify a ductal carcinoma in situ (DCIS) patient population at low risk of upgrade to invasive carcinoma?
BACKGROUND: The Surgery versus Active Monitoring for Low-Risk DCIS (LORIS) trial is studying the safety of monitoring core-biopsy diagnosed low-risk ductal carcinoma in situ (DCIS) without excision. We sought to determine the incidence and characteristics of synchronous invasive carcinoma found in L...
保存先:
| 出版年: | Ann Surg Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070657/ https://ncbi.nlm.nih.gov/pubmed/27172775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5268-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|